http://rdf.ncbi.nlm.nih.gov/pubchem/patent/NZ-574194-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cf32b60391b469c41e86c353437f5751
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D493-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-425
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D493-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-425
filingDate 2007-08-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_28fb8a9edefb8227b413e1377f9db32b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8f96f51b5214f8089f8961d580d6cb2b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_10843e1a69b88cdca739d49c3a92f7e0
publicationDate 2011-12-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber NZ-574194-A
titleOfInvention Crystal form of epothilone b and use in pharmaceutical compositions
abstract Disclosed herein is a crystal form of epothilone B having the reference modification C, which is characterised by X-ray diffraction with strong intensity at 17.5 and 18.3. Also disclosed are processes for its preparation, compositions comprising said crystal form and the use thereof in the preparation of a medicament for treating a proliferative disease.
priorityDate 2006-08-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449319262
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425879419
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5354357
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10467
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451466641
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID637517
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID13849
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID447865
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID408978442
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410078110
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID408335764
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419486422
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID456986880
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID158457124
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419644899
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID433322215
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID154496523
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426079355
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415968435
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5281116
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425534311
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425073573
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6360
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID46936553
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8907
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10465
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415968632
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID448799
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448897384
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419530439
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID198429
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415778323
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3587356
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24441
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12530
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID84338

Total number of triples: 54.